Cargando…

Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease

With the number of cases of coronavirus disease-2019 (COVID-19) increasing rapidly, the World Health Organization (WHO) has recommended that patients with mild or moderate symptoms could be released from quarantine without nucleic acid retesting, and self-isolate in the community. This may pose a po...

Descripción completa

Detalles Bibliográficos
Autores principales: YUAN, Shijin, PAN, Yong, XIA, Yan, ZHANG, Yan, CHEN, Jiangnan, ZHENG, Wei, XU, Xiaoping, XIE, Xinyou, ZHANG, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Zhejiang University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042531/
https://www.ncbi.nlm.nih.gov/pubmed/33835766
http://dx.doi.org/10.1631/jzus.B2000608
_version_ 1783678144288391168
author YUAN, Shijin
PAN, Yong
XIA, Yan
ZHANG, Yan
CHEN, Jiangnan
ZHENG, Wei
XU, Xiaoping
XIE, Xinyou
ZHANG, Jun
author_facet YUAN, Shijin
PAN, Yong
XIA, Yan
ZHANG, Yan
CHEN, Jiangnan
ZHENG, Wei
XU, Xiaoping
XIE, Xinyou
ZHANG, Jun
author_sort YUAN, Shijin
collection PubMed
description With the number of cases of coronavirus disease-2019 (COVID-19) increasing rapidly, the World Health Organization (WHO) has recommended that patients with mild or moderate symptoms could be released from quarantine without nucleic acid retesting, and self-isolate in the community. This may pose a potential virus transmission risk. We aimed to develop a nomogram to predict the duration of viral shedding for individual COVID-19 patients. This retrospective multicentric study enrolled 135 patients as a training cohort and 102 patients as a validation cohort. Significant factors associated with the duration of viral shedding were identified by multivariate Cox modeling in the training cohort and combined to develop a nomogram to predict the probability of viral shedding at 9, 13, 17, and 21 d after admission. The nomogram was validated in the validation cohort and evaluated by concordance index (C-index), area under the curve (AUC), and calibration curve. A higher absolute lymphocyte count (P=0.001) and lymphocyte-to-monocyte ratio (P=0.013) were correlated with a shorter duration of viral shedding, while a longer activated partial thromboplastin time (P=0.007) prolonged the viral shedding duration. The C-indices of the nomogram were 0.732 (95% confidence interval (CI): 0.685‒0.777) in the training cohort and 0.703 (95% CI: 0.642‒0.764) in the validation cohort. The AUC showed a good discriminative ability (training cohort: 0.879, 0.762, 0.738, and 0.715 for 9, 13, 17, and 21 d; validation cohort: 0.855, 0.758, 0.728, and 0.706 for 9, 13, 17, and 21 d), and calibration curves were consistent between outcomes and predictions in both cohorts. A predictive nomogram for viral shedding duration based on three easily accessible factors was developed to help estimate appropriate self-isolation time for patients with mild or moderate symptoms, and to control virus transmission.
format Online
Article
Text
id pubmed-8042531
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Zhejiang University Press
record_format MEDLINE/PubMed
spelling pubmed-80425312021-04-16 Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease YUAN, Shijin PAN, Yong XIA, Yan ZHANG, Yan CHEN, Jiangnan ZHENG, Wei XU, Xiaoping XIE, Xinyou ZHANG, Jun J Zhejiang Univ Sci B Research Article With the number of cases of coronavirus disease-2019 (COVID-19) increasing rapidly, the World Health Organization (WHO) has recommended that patients with mild or moderate symptoms could be released from quarantine without nucleic acid retesting, and self-isolate in the community. This may pose a potential virus transmission risk. We aimed to develop a nomogram to predict the duration of viral shedding for individual COVID-19 patients. This retrospective multicentric study enrolled 135 patients as a training cohort and 102 patients as a validation cohort. Significant factors associated with the duration of viral shedding were identified by multivariate Cox modeling in the training cohort and combined to develop a nomogram to predict the probability of viral shedding at 9, 13, 17, and 21 d after admission. The nomogram was validated in the validation cohort and evaluated by concordance index (C-index), area under the curve (AUC), and calibration curve. A higher absolute lymphocyte count (P=0.001) and lymphocyte-to-monocyte ratio (P=0.013) were correlated with a shorter duration of viral shedding, while a longer activated partial thromboplastin time (P=0.007) prolonged the viral shedding duration. The C-indices of the nomogram were 0.732 (95% confidence interval (CI): 0.685‒0.777) in the training cohort and 0.703 (95% CI: 0.642‒0.764) in the validation cohort. The AUC showed a good discriminative ability (training cohort: 0.879, 0.762, 0.738, and 0.715 for 9, 13, 17, and 21 d; validation cohort: 0.855, 0.758, 0.728, and 0.706 for 9, 13, 17, and 21 d), and calibration curves were consistent between outcomes and predictions in both cohorts. A predictive nomogram for viral shedding duration based on three easily accessible factors was developed to help estimate appropriate self-isolation time for patients with mild or moderate symptoms, and to control virus transmission. Zhejiang University Press 2021-04-15 /pmc/articles/PMC8042531/ /pubmed/33835766 http://dx.doi.org/10.1631/jzus.B2000608 Text en © Zhejiang University Press 2021
spellingShingle Research Article
YUAN, Shijin
PAN, Yong
XIA, Yan
ZHANG, Yan
CHEN, Jiangnan
ZHENG, Wei
XU, Xiaoping
XIE, Xinyou
ZHANG, Jun
Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease
title Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease
title_full Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease
title_fullStr Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease
title_full_unstemmed Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease
title_short Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease
title_sort development and validation of an individualized nomogram for early prediction of the duration of sars-cov-2 shedding in covid-19 patients with non-severe disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042531/
https://www.ncbi.nlm.nih.gov/pubmed/33835766
http://dx.doi.org/10.1631/jzus.B2000608
work_keys_str_mv AT yuanshijin developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT panyong developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT xiayan developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT zhangyan developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT chenjiangnan developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT zhengwei developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT xuxiaoping developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT xiexinyou developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease
AT zhangjun developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease